ITBusiness.ca

The Astellas Oncology C3 prize is looking for Canadians with an entrepreneurial spirit

Calling all Canadian innovators! The Astellas Oncology C3 prize is offering $100,000 USD in grants for cutting-edge non-medical approaches to helping cancer patients.

“We’re really trying to get people who have a passion for this and have some ideas that are in the non-medical, non-treatment area,” says Michael Tremblay, president of Astellas Pharma Canada.

The contest is open to all North-Americans, and will be accepting entries April 25-Aug. 8. While it is not specified that ideas must relate to technology, Tremblay says “a lot of these areas could be enhanced by technology, that’s why we’re leaving it really, really wide open.”

The contest’s website advises innovators use these four areas as guidelines for focusing their ideas:

This is the inaugural year of the contest, started because of a void in the area, Tremblay says. Its focus is to help patients, as well as caregivers and loved ones, through one of the most difficult challenges life has to offer. Furthermore, Tremblay hopes the challenge will spark the entrepreneurial spirit in people whilst benefiting an excellent cause.

Finalists will be notified on Aug. 15, and will be required to pitch their ideas to a group of judges at Stanford Medicine on Sept. 17. First place will receive a grant of $50,000, with second and third each receiving $25,000. For guidance on how to commercialize their ideas, winners will also be given access to the Chicago-based think tank, Matter.

Contest organizers are eager for Canadian submissions, and Tremblay says he hopes to see at least one of the grants go to a Canadian group or person.

Exit mobile version